These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 6965609)
21. Epidermal growth factor, like phorbol esters, induces plasminogen activator in HeLa cells. Lee LS; Weinstein IB Nature; 1978 Aug; 274(5672):696-7. PubMed ID: 307695 [No Abstract] [Full Text] [Related]
22. Retinoids enhance mitogenesis by tumour promotor and polypeptide growth factors. Dicker P; Rozengurt E Biochem Biophys Res Commun; 1979 Dec; 91(4):1203-10. PubMed ID: 316701 [No Abstract] [Full Text] [Related]
23. Induction of monocyte-macrophage differentiation in a new diploid line of human hematopoietic cells (CM-S) by phorbol esters. Monaco G; Vigneti E; Lancieri M; Cornaglia-Ferraris P; Lambertenghi-Deliliers G; Revoltella R Cancer Res; 1982 Oct; 42(10):4182-9. PubMed ID: 7105012 [No Abstract] [Full Text] [Related]
24. Changes in epidermal growth factor receptors associated with adenovirus transformation, chemical carcinogen transformation and exposure to a phorbol ester tumor promoter. Fisher PB; Lee LS; Weinstein IB Biochem Biophys Res Commun; 1980 Apr; 93(4):1160-6. PubMed ID: 6249279 [No Abstract] [Full Text] [Related]
25. Effects of 12-0-Tetradecanoylphorbol-13-acetate (TPA) on rat pheochromocytoma (PC12) cells: interactions with epidermal growth factor and nerve growth factor. End D; Tolson N; Yu MY; Guroff G J Cell Physiol; 1982 May; 111(2):140-8. PubMed ID: 6979547 [TBL] [Abstract][Full Text] [Related]
26. Hexose transport in undifferentiated and differentiated BALB/c 3T3 preadipose cells: effects 12-O-tetradecanoylphorbol-13-acetate and insulin. O'Brien TG J Cell Physiol; 1982 Jan; 110(1):63-71. PubMed ID: 7040424 [No Abstract] [Full Text] [Related]
27. Inhibition of epidermal growth factor binding to surface receptors by tumor promotors. Brown KD; Dicker P; Rozengurt E Biochem Biophys Res Commun; 1979 Feb; 86(4):1037-43. PubMed ID: 312103 [No Abstract] [Full Text] [Related]
28. Regulation of growth and differentiation by phorbol esters and the mechanism of tumor promotion. Lotem J; Sachs L Carcinog Compr Surv; 1982; 7():385-90. PubMed ID: 6978180 [TBL] [Abstract][Full Text] [Related]
29. Modulation of terminal differentiation and responses to tumor promoters by retinoids in mouse epidermal cell cultures. Yuspa SH; Lichti U; Ben T; Hennings H Ann N Y Acad Sci; 1981 Feb; 359():260-73. PubMed ID: 6942677 [No Abstract] [Full Text] [Related]
30. Induction of chemotaxis in mouse peritoneal macrophages by phorbol ester tumor promoters. Laskin DL; Laskin JD; Weinstein IB; Carchman RA Cancer Res; 1981 May; 41(5):1923-8. PubMed ID: 7214360 [TBL] [Abstract][Full Text] [Related]
31. Tumor promoters and Kirsten sarcoma virus increase synthesis of a secreted glycoprotein by regulating levels of translatable mRNA. Gottesman MM; Sobel ME Cell; 1980 Feb; 19(2):449-55. PubMed ID: 6244111 [No Abstract] [Full Text] [Related]
32. Suppression of natural tumor resistance by tumor promoters. Keller R; Keist R; Köppel P; Hecker E Carcinog Compr Surv; 1982; 7():643-5. PubMed ID: 7039836 [TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms. Kanter P; Leister KJ; Tomei LD; Wenner PA; Wenner CE Biochem Biophys Res Commun; 1984 Jan; 118(2):392-9. PubMed ID: 6608349 [TBL] [Abstract][Full Text] [Related]
34. Induction of macrophage DNA synthesis by phorbol esters. Hamilton JA; Dientsman SR J Cell Physiol; 1981 Mar; 106(3):445-50. PubMed ID: 7194349 [TBL] [Abstract][Full Text] [Related]
35. Epidermal cell cycle and transit times during hyperplastic growth induced by abrasion or treatment with 12-O-tetradecanoylphorbol-13-acetate. Morris R; Argyris TS Cancer Res; 1983 Oct; 43(10):4935-42. PubMed ID: 6883343 [No Abstract] [Full Text] [Related]
36. Phagocytic activity of the tumor associated macrophages in relation to tumor growth: modulation with levamisole. Bhattacharyya S; Chakrabarty NG; Chattopadhyay U Neoplasma; 1986; 33(4):519-26. PubMed ID: 3762811 [TBL] [Abstract][Full Text] [Related]
37. Initiator and promoter induced specific changes in epidermal function and biological potential. Yuspa SH; Hennings H; Lichti U J Supramol Struct Cell Biochem; 1981; 17(3):245-57. PubMed ID: 7328673 [TBL] [Abstract][Full Text] [Related]
38. Variants of 3T3 cells lacking mitogenic response to the tumor promoter tetradecanoyl-phorbol-acetate. Butler-Gralla E; Herschman HR J Cell Physiol; 1981 Apr; 107(1):59-67. PubMed ID: 6971296 [TBL] [Abstract][Full Text] [Related]
39. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673 [TBL] [Abstract][Full Text] [Related]
40. Induction by tumor-promoting phorbol diester of colony-stimulating activity in human myeloid leukemia cells transformed to macrophage-mimicking cells. Svet-Moldavskaya IA; Arlin Z; Svet-Moldavsky GJ; Clarkson BD; Koziner B; Mendelsohn N; Zinzar SN; Holland JF Cancer Res; 1981 Nov; 41(11 Pt 1):4335-40. PubMed ID: 6975651 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]